Ads
related to: Abbvie and Opioid
Search results
The $5 BILLION Reason Alpine Immune Sciences (ALPN) Stock Is Up 30% Today
InvestorPlace· 1 week agoDrug maker Alpine Immune Sciences (NASDAQ:ALPN) got a $4.9 billion buyout offer from Vertex...
No end to surprise-billing surprises
Politico· 2 days agoFormer pharmaceutical and biotech firm executives Michel Vounatsos (Biogen), Rob Scott (AbbVie) and Christian Hein (Novartis) are joining QuantHealth’s inaugural advisory ...
Oncologists Voice Ethical Concerns Over AI in Cancer Care
Medscape· 1 week agoA survey of oncologists highlighted ethical issues over the use of AI in cancer care and revealed some contradictory views about how best to integrate these tools.
